In glioma, ∼74% of Treg isolated from the peripheral blood of GBM patients express CCR4, which is significantly increased when compared to the ∼43% of Treg expressing CCR4 in healthy (control) patients (Jordan et al., 2008). Here, CCR4 is linked to glioblastoma.